Clinical Trials Logo
  1. Home
  2. Dyspnea
  3. NCT03276507
  4. Details
NCT03276507 Clinical Trial

Multisystem Shortness of Breath Evaluation Study

Dyspnea Clinical Trial

— MUSE  

Official title:
Multisystem Shortness of Breath Evaluation Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03276507
Other study ID # EO 113/2016_FJD
Secondary ID
Status Recruiting
Phase N/A
First received September 7, 2017
Last updated November 8, 2017
Start date November 1, 2016
Est. completion date June 1, 2018

Study information
Verified date November 2017
Source Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Contact Luis M Seijo, MD
Phone 91 550 4800
Email luis.seijo@fjd.es
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The MUSE study is a prospective observational cohort study of patients referred to pulmonary and/or cardiology specialty clinic for evaluation of shortness of breath or dyspnea. Patients will undergo all pertinent testing and will be required to fill out a number of epidemiologic and quality of life related questionnaires. Follow up will continue for at least one year.

Recruitment information / eligibility
Status Recruiting
Enrollment 60
Est. completion date June 1, 2018
Est. primary completion date December 1, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Patients referred to Pulmonary and/or Cardiology clinic for the evaluation of unexplained dyspnea.

Exclusion Criteria:

- Patients with a known cause of dyspnea such as established cardiopulmonary disease

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Pulmonary function studies

• Echocardiogram

• Electrocardiogram

• Chest radiography

• Blood test

Behavioral:
• Quality of life questionnaire

Locations
Country Name City State
Spain Fundación Jimenez Díaz Madrid

Sponsors (1)
Lead Sponsor Collaborator
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Dyspnea etiology All patients will undergo cardiopulmonary testing and will be offered quiestionnaires including the M3 online questionnaire 3 months
Secondary Quality of Life Several questionnaires will be used including the M3 questionnaire 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04688905 - Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)
Completed NCT03679312 - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD Phase 1/Phase 2
Recruiting NCT04868357 - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program N/A
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Completed NCT03626519 - Effects of Menthol on Dyspnoea in COPD Patients N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Terminated NCT02269761 - Chest Ultrasound of ER Patients With Cough or SOB
Completed NCT02248831 - Evaluation of Cardiopulmonary Diseases by Ultrasound N/A
Completed NCT02538770 - Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization N/A
Recruiting NCT01655199 - Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease N/A
Active, not recruiting NCT01440764 - Aerosol Inhalation Treatment for Dyspnea Phase 1/Phase 2
Completed NCT01577407 - Non Opioid Treatment for Experimental Dyspnea Phase 3
Completed NCT01193998 - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department N/A
Recruiting NCT04327882 - Point-of-care Ultrasound Interest in Dyspneic Emergency Department Patients: an Observational Bicentric Study
Completed NCT05029986 - Preventing Dyspnea During Speech in Older Speakers N/A
Not yet recruiting NCT04181359 - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease. Phase 1/Phase 2
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed NCT04305639 - The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"
Completed NCT04375917 - Is Reduced Hypoxia Through a Robot Intervention, Associated With Sensory and Emotional Descriptions of Dyspnea, Anxiety, Depression, Symptom Burden and Anxiolytics N/A
Completed NCT04370990 - Automated Oxygen Administration -Rethinking Interventions Alleviating Dyspnea in Patients With COPD N/A